205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.63%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-7.29%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-5.86%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-6.38%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-0.12%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.26%
Share reduction while MPWR is at 0.06%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.02%
Reduced diluted shares while MPWR is at 1.50%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
13.02%
Dividend growth above 1.5x MPWR's 0.36%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-8.03%
Negative OCF growth while MPWR is at 28.28%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-10.39%
Negative FCF growth while MPWR is at 31.73%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
70.78%
10Y revenue/share CAGR under 50% of MPWR's 262.98%. Michael Burry would suspect a lasting competitive disadvantage.
29.09%
5Y revenue/share CAGR at 50-75% of MPWR's 46.66%. Martin Whitman would worry about a lagging mid-term growth trajectory.
3.75%
3Y revenue/share CAGR under 50% of MPWR's 38.73%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
60.55%
10Y OCF/share CAGR under 50% of MPWR's 1300.85%. Michael Burry would worry about a persistent underperformance in cash creation.
50.79%
5Y OCF/share CAGR above 1.5x MPWR's 14.78%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
42.19%
3Y OCF/share CAGR 1.25-1.5x MPWR's 34.64%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
177.33%
Below 50% of MPWR's 1868.43%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
49.47%
5Y net income/share CAGR at 50-75% of MPWR's 71.67%. Martin Whitman might see a shortfall in operational efficiency or brand power.
200.49%
3Y net income/share CAGR similar to MPWR's 214.15%. Walter Schloss would attribute it to shared growth factors or demand patterns.
31.01%
Below 50% of MPWR's 287.10%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
26.82%
5Y equity/share CAGR at 50-75% of MPWR's 46.69%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
2.97%
Below 50% of MPWR's 24.06%. Michael Burry suspects a serious short-term disadvantage in building book value.
1232.73%
Dividend/share CAGR of 1232.73% while MPWR is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
183.53%
Dividend/share CAGR of 183.53% while MPWR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
100.21%
3Y dividend/share CAGR of 100.21% while MPWR is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-15.64%
Firm’s AR is declining while MPWR shows 5.59%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
1.88%
We show growth while MPWR is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-0.99%
Negative asset growth while MPWR invests at 1.70%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.49%
Under 50% of MPWR's 1.34%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-0.06%
We’re deleveraging while MPWR stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-6.33%
Our R&D shrinks while MPWR invests at 1.78%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-7.34%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.